101
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Design of Nano-Clays for Drug Delivery and Bio-Imaging: Can Toxicity Be An Issue?

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 2429-2432 | Received 07 Jul 2020, Accepted 10 Aug 2020, Published online: 03 Sep 2020

References

  • Nel A , XiaT, MadlerL, LiN. Toxic potential of materials at the nanolevel. Science311(5761), 622–627 (2006).
  • Peña-Parás L , Sánchez-FernándezJA, VidaltamayoR. Nanoclays for biomedical applications. In: Handbook of Ecomaterials.MartínezLMT, KharissovaOV, KharisovBI ( Eds). Springer International Publishing, Switzerland, 1–19 (2018).
  • Nadziakiewicza M , KehoeS, MicekP. Physico–chemical properties of clay minerals and their use as a health promoting feed additive. Animals9(10), 714 (2019).
  • Naumenko EA , FakhrullinRF. Toxicological evaluation of clay nanomaterials and polymer–clay nanocomposites. In: Functional Polymer Composites with Nanoclays.LvovY, GuoB, ( Eds). Royal Society of Chemistry Publishing, London, UK, 399–419 (2017).
  • Lvov Y , PanchalA, FuY, FakhrullinRet al. Interfacial self-assembly in halloysite nanotube composites. Langmuir35(26), 8646–8657 (2019).
  • Satish S , TharmavaramM, RawtaniD. Halloysite nanotubes as a nature’s boon for biomedical applications. Nanobiomedicine6, 1849543519863625 (1-16) (2019).
  • Jafarbeglou M , AbdoussM, ShoushtariAM, JafarbeglouM. Clay nanocomposites as engineered drug delivery systems. RSC Adv.6(55), 50002–50016 (2016).
  • Ekaterina A , Naumenko, FakhrullinRF. “Toxicological Evaluation of Clay Nanomaterials and Polymer–Clay Nanocomposites” Chapter 15. Functional Polymer Composites with Nanoclays.LvovY, GuoB, FakhrullinRF. ( Eds). Royal Society of Chemistry Publishing, London, UK (2016).
  • Saleh MY , PrajapatiN, DeCosterMA, LvovY. Tagged halloysite nanotubes as a carrier for intercellular delivery in brain microvascular endothelium. Front. Bioeng. Biotechnol.8, 451 (2020).
  • Prieto E , VispeE, DeMartino Aet al. Safety study of intravitreal and suprachoroidal laponite clay in rabbit eyes. Graefes Arch. Clin. Exp. Opthalmol.256(3), 535–546 (2018).
  • Jia L , ZhouT, XuJet al. Visible light-induced lanthanide polymer nanocomposites based on clays for bioimaging applications. J. Mater. Sci.51(3), 1324–1332 (2016).
  • Liu H , WangZG, LiuSLet al. Intracellular pathway of halloysite nanotubes: potential application for antitumor drug delivery. J. Mater. Sci.54(1), 693–704 (2019).
  • Zhou T , JiaL, LuoYFet al. Multifunctional nanocomposite based on halloysite nanotubes for efficient luminescent bioimaging and magnetic resonance imaging. Int. J. Nanomedicine2016(11), 4765–4776 (2016).
  • Fakhrullina GI , AkhatovaFS, LvovYM, FakhrullinRF. Toxicity of halloysite clay nanotubes in vivo: a caenorhabditis elegans study. Environ. Sci. Nano2(1), 54–59 (2015).
  • Vergaro V , AbdullayevE, LvovYMet al. Cytocompatibility and uptake of halloysite clay nanotubes. Biomacromolecules11(3), 820–826 (2010).
  • Leporatti S . Halloysite clay nanotubes as nano-bazookas for drug delivery. Poly. Int.66(8), 1111–1118 (2017).
  • Sanchez-Fernandez A , Pena-ParasL, VidaltamayoRet al. Synthesization, characterization, and in vitro evaluation of cytotoxicity of biomaterials based on halloysite nanotubes. Materials (Basel)7(12), 7770–7780 (2014).
  • Abhinayaa R , JeevithaG, MangalarajD, PonpandianN, VidhyaK, AngayarkanniJ. Cytotoxic consequences of halloysite nanotube/iron oxide nanocomposite and iron oxide nanoparticles upon interaction with bacterial, non-cancerous and cancerous cells. Colloids Surf. B Biointerfaces169(1), 395–403 (2018).
  • Hu T , GuiZ, GongJet al. INOS-mediated acute stomach injury and recovery in mice after oral exposure to halloysite nanotubes. Environ. Pollut.258, 113758 (2020).
  • Ahmed FR , ShoaibMH, AzharMet al. In-vitro assessment of cytotoxicity of halloysite nanotubes against hepg2, hct116 and human peripheral blood lymphocytes. Colloids Surf. B Biointerfaces135, 50–55 (2015).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.